TY - JOUR
T1 - Imagery-enhanced v. verbally-based group cognitive behavior therapy for social anxiety disorder
T2 - a randomized clinical trial
AU - McEvoy, Peter M.
AU - Hyett, Matthew P.
AU - Bank, Samantha R.
AU - Erceg-Hurn, David M.
AU - Johnson, Andrew R.
AU - Kyron, Michael J.
AU - Saulsman, Lisa M.
AU - Moulds, Michelle L.
AU - Grisham, Jessica R.
AU - Holmes, Emily A.
AU - Moscovitch, David A.
AU - Lipp, Ottmar V.
AU - Campbell, Bruce N. C.
AU - Rapee, Ronald M.
PY - 2022/5
Y1 - 2022/5
N2 - BackgroundCognitive behavior therapy (CBT) is effective for most patients with a social anxiety disorder (SAD) but a substantial proportion fails to remit. Experimental and clinical research suggests that enhancing CBT using imagery-based techniques could improve outcomes. It was hypothesized that imagery-enhanced CBT (IE-CBT) would be superior to verbally-based CBT (VB-CBT) on pre-registered outcomes.MethodsA randomized controlled trial of IE-CBT v. VB-CBT for social anxiety was completed in a community mental health clinic setting. Participants were randomized to IE (n = 53) or VB (n = 54) CBT, with 1-month (primary end point) and 6-month follow-up assessments. Participants completed 12, 2-hour, weekly sessions of IE-CBT or VB-CBT plus 1-month follow-up.ResultsIntention to treat analyses showed very large within-treatment effect sizes on the social interaction anxiety at all time points (ds = 2.09-2.62), with no between-treatment differences on this outcome or clinician-rated severity [1-month OR = 1.45 (0.45, 4.62), p = 0.53; 6-month OR = 1.31 (0.42, 4.08), p = 0.65], SAD remission (1-month: IE = 61.04%, VB = 55.09%, p = 0.59); 6-month: IE = 58.73%, VB = 61.89%, p = 0.77), or secondary outcomes. Three adverse events were noted (substance abuse, n = 1 in IE-CBT; temporary increase in suicide risk, n = 1 in each condition, with one being withdrawn at 1-month follow-up).ConclusionsGroup IE-CBT and VB-CBT were safe and there were no significant differences in outcomes. Both treatments were associated with very large within-group effect sizes and the majority of patients remitted following treatment.
AB - BackgroundCognitive behavior therapy (CBT) is effective for most patients with a social anxiety disorder (SAD) but a substantial proportion fails to remit. Experimental and clinical research suggests that enhancing CBT using imagery-based techniques could improve outcomes. It was hypothesized that imagery-enhanced CBT (IE-CBT) would be superior to verbally-based CBT (VB-CBT) on pre-registered outcomes.MethodsA randomized controlled trial of IE-CBT v. VB-CBT for social anxiety was completed in a community mental health clinic setting. Participants were randomized to IE (n = 53) or VB (n = 54) CBT, with 1-month (primary end point) and 6-month follow-up assessments. Participants completed 12, 2-hour, weekly sessions of IE-CBT or VB-CBT plus 1-month follow-up.ResultsIntention to treat analyses showed very large within-treatment effect sizes on the social interaction anxiety at all time points (ds = 2.09-2.62), with no between-treatment differences on this outcome or clinician-rated severity [1-month OR = 1.45 (0.45, 4.62), p = 0.53; 6-month OR = 1.31 (0.42, 4.08), p = 0.65], SAD remission (1-month: IE = 61.04%, VB = 55.09%, p = 0.59); 6-month: IE = 58.73%, VB = 61.89%, p = 0.77), or secondary outcomes. Three adverse events were noted (substance abuse, n = 1 in IE-CBT; temporary increase in suicide risk, n = 1 in each condition, with one being withdrawn at 1-month follow-up).ConclusionsGroup IE-CBT and VB-CBT were safe and there were no significant differences in outcomes. Both treatments were associated with very large within-group effect sizes and the majority of patients remitted following treatment.
KW - cognitive behavior therapy
KW - fear of negative evaluation
KW - group therapy
KW - imagery
KW - randomized controlled trial
KW - social anxiety disorder
KW - social interaction anxiety
UR - http://www.scopus.com/inward/record.url?scp=85091756275&partnerID=8YFLogxK
UR - http://purl.org/au-research/grants/nhmrc/1104007
U2 - 10.1017/S0033291720003001
DO - 10.1017/S0033291720003001
M3 - Article
C2 - 32912351
AN - SCOPUS:85091756275
SN - 0033-2917
VL - 52
SP - 1277
EP - 1286
JO - Psychological Medicine
JF - Psychological Medicine
IS - 7
ER -